The Royal College of General Practitioners (RCGP) and the MHRA Clinical Practice Research Datalink (CPRD) have developed confidential bespoke practice and patient-level drug prescribing reports, available for free for GP practices contributing to CPRD.
The reports focus on prescribing and patient safety, allowing practices to benchmark themselves against others contributing to CPRD. The reports can be used for appraisal (under Domain 2 – Safety & Quality) and revalidation.
The reports currently include four indicators:
- Prescription of NSAIDs to patients with heart failure
- Prescription of glitazones to patients with heart failure
- Prescription of NSAIDs to patients with chronic kidney disease (CKD)
- Aspirin monotherapy for stroke prevention in patients with atrial fibrillation
Additional indicators are being developed for inclusion later in the year. Further information and example reports can be found on the RCGP/CPRD Quality Improvement Project webpage.